The clinical data analytics platform firm has raised $75m since 2015 and will continue to enhance both the platform and applications with new capabilities, says CEO.
Clinical AI, no matter how sophisticated, cannot work on its own, says Life Image CEO, who predicts that CROs will either adapt or be disrupted by smaller companies with digital access capabilities.
WuXi STA becomes the preferred CDMO partner for Beta Pharma as the company launches a Phase II clinical trial in China and begins preclinical research for an additional target.
BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.
Synteract is opening a new office in Swansea, Wales in response to increased demand across its core therapeutic areas for both full-service work and more consultative, standalone projects, says CEO.
WCG’s new SiteReady solution looks to alleviate the challenges facing research teams, helping clinical trial sites remain “highly ranked” with sponsors.
As clinical trials create large amounts of data, and researchers seize the opportunity to use de-identified data as a means to develop and discovery, managing the information has become more and more complex.
Optibrium develops software for drug discovery and today announces a collaboration with InfoChem GmbH, a cheminformatics company, to provide users with a computer-aided synthesis design tool.
Evotec is partnering with a global non-profit research group to develop a pipeline of novel antibiotics after integrating Sanofi’s infectious disease unit last year.
The global software consulting company N-Side recently launched an end-to-end clinical trial supply chain management solution to enable “agile” decision making and reduce drug waste.
Alternatives to the transactional RFP-bid defense structure “invite greater creativity and innovative options” into sourcing discussions, says Syneos executive.
